DWM
TXG icon

Dynasty Wealth Management’s 10x Genomics TXG Stock Holding History

Dynasty Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Sell
19,919
-5,336
-21% -$107K ﹤0.01% 252
2025
Q4 		$412K Buy
25,255
+1,307
+5% +$19.7K ﹤0.01% 252
2025
Q3 		$280K Buy
+23,948
New +$312K ﹤0.01% 268

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynasty Wealth Management's TXG Position: Q1 2026 in Review

Dynasty Wealth Management reduced its 10x Genomics (TXG) stake by 21% in Q1 2026, selling an estimated $107K and leaving 19,919 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Dynasty Wealth Management first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Dynasty Wealth Management held 19,919 shares of 10x Genomics worth $423K as of Q1 2026.
  • Dynasty Wealth Management sold 5,336 10x Genomics shares in Q1 2026, an estimated $107K.
  • 10x Genomics made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q1 2026, its #252 holding.
  • Dynasty Wealth Management first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.